EUVIMEDOpdag EUVIMED
Crossref

Amber Codon Mutational Scanning and Bioorthogonal PEGylation for Epitope Mapping of Antibody Binding Sites on Human Arginase-1

Jaime Fernández de Santaella iD, Nikolaj G Koch iD, Lorenz Widmer, Michael A Nash iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.4c00692 ↗

At a glance

Journal article in ACS Chemical Biology, 2025. Written by Jaime Fernández de Santaella and 3 co-authors. Institution: Institute of Physical Chemistry, Department of Chemistry, University of Basel, 4058 Basel, Switzerland. Major MEDLINE topics: Epitope Mapping, Arginase, Polyethylene Glycols, Binding Sites, Antibody. Cited 1 times so far (Crossref); 58 references. Funded by: Eidgen?ssische Technische Hochschule Z?rich, Staatssekretariat f?r Bildung, Forschung und Innovation, Universit?t Basel.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Epitope mapping is crucial for understanding immunological responses to protein therapeutics. Here, we combined genetic code expansion and bacterial surface display to incorporate S-allylcysteine (SAC) into human arginase-1 (hArg1) via Methanococcoides burtonii pyrrolysyl-tRNA synthetase. Using an amber codon deep mutational scanning and sequencing workflow, we mapped SAC incorporation efficiency across the hArg1 sequence, providing insights into structural and sequence dependencies of noncanonical amino acid incorporation. We used mutually bioorthogonal allyl/tetrazine and azide/DBCO chemistries to achieve site-specific PEGylation and fluorescent labeling of hArg1, revealing insights into SAC side chain reactivity and solvent accessibility of residues in hArg1. This system was further applied to determine the binding epitope of a monoclonal antibody on the surface of hArg1, providing high-resolution data on the impact of PEGylation residue position on antibody binding. Our method produces high dimensional data of noncanonical amino acid incorporation efficiency, site-specific functionalization enabled by mutually bioorthogonal chemistries, and epitope mapping of therapeutic proteins.

Subjects

MeSH terms (MEDLINE)

Epitope MappingArginasePolyethylene GlycolsBinding Sites, AntibodyCodon, TerminatorHumansBinding SitesAntibodies, Monoclonal

Substances

ArginasePolyethylene GlycolsARG1 protein, humanCodon, TerminatorAntibodies, Monoclonal

Authors and institutions

  • Institute of Physical Chemistry, Department of Chemistry, University of Basel, 4058 Basel, Switzerland.
  • Department of Biosystems Science and Engineering, ETH Zurich, 4056 Basel, Switzerland.
  • National Center for Competence in Research (NCCR), Molecular Systems Engineering, 4058 Basel, Switzerland.
  • Swiss Nanoscience Institute, 4056 Basel, Switzerland.

ORCID profiles: Jaime Fernández de Santaella, Nikolaj G Koch, Michael A Nash

Funding

  • Eidgen?ssische Technische Hochschule Z?rich
  • Staatssekretariat f?r Bildung, Forschung und Innovation
  • Universit?t Basel

Cite

APA

Fernández de Santaella, J., Koch, N. G., Widmer, L., & Nash, M. A. (2025). Amber Codon Mutational Scanning and Bioorthogonal PEGylation for Epitope Mapping of Antibody Binding Sites on Human Arginase-1. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00692

Vancouver

Fernández de Santaella J, Koch NG, Widmer L, Nash MA. Amber Codon Mutational Scanning and Bioorthogonal PEGylation for Epitope Mapping of Antibody Binding Sites on Human Arginase-1. ACS Chemical Biology. 2025. doi:10.1021/acschembio.4c00692

BibTeX
@article{FernndezdeSantaella2025,
  author = {Fernández de Santaella, Jaime and Koch, Nikolaj G and Widmer, Lorenz and Nash, Michael A},
  title = {Amber Codon Mutational Scanning and Bioorthogonal PEGylation for Epitope Mapping of Antibody Binding Sites on Human Arginase-1},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.4c00692}
}
Start for free →